Galectin Therapeutics
GALT
GALT
45 hedge funds and large institutions have $8.34M invested in Galectin Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
5
Closed
2
Calls
$784K
Puts
$272K
Net Calls
+$512K
Net Calls Change
+$449K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.7M |
2 |
2
Charles Schwab
San Francisco,
California
|
$351K |
3 |
3
BlackRock
New York
|
$298K |
4 |
4
Morgan Stanley
New York
|
$206K |
5 |
DADC
5
D.A. Davidson & Co
Great Falls,
Montana
|
$1.84M |